As Manitoba adopts permanent daylight saving time, clinicians must consider health outcomes.

Our first ‘NP of the Month’ is changing the lives of postpartum women of color in Maryland.

Mountaintop, arctic, or backwoods — wilderness medicine offers adventure and invaluable lessons for nurse practitioners and physician assistants.

What makes GLP-1 super responders — patients who rapidly exceed normal weight loss on these agents — unique?

From journal and guideline summaries to misguided medicine, hospitalists are tuning into podcasts in record numbers.

New research adds to the data suggesting a benefit of pairing ketamine with psychotherapy for treating pain and other conditions.

Ketamine cystitis causes irreversible damage but is often caught too late.

Child obesity has a paternal component, offering important clinical opportunities for interventions.

Even the savviest ER Doc is puzzled by Cannabinoid Hyperemesis Syndrome.

Are your patients Zyn-ing? Contraband nicotine patches are the latest wellness trend in Canada.

Adult-gerontology nurse practitioners might be the future of elder care as opportunities grow.

Ontario opens access to repetitive transcranial magnetic stimulation treatment for thousands with treatment-resistant depression.

Fat shaming is now slim shaming, and patients with obesity on GLP-1s are taking the heat.

Ontario Health is poised to lower the colorectal cancer screening age to 45 years on July 1.

Will nurse practitioners step into the demand for menopause education and management?

The pandemic delivered unseen benefits. Now virtual hospitalists and patients are reaping the rewards.

Experts warn that new tick species in Canada can confound diagnosis.

A new take-home tablet is in development, but will the features that make it attractive blunt the experience that could be part of ketamine’s therapeutic value?

The COVID seasonal vaccine for 2025/2026 protects patients not only from the target strain but also from other SARS-CoV-2 variants.

Clinicians should be aware of claims being made about unregulated peptides and the potential harms associated with these products.